30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Cue Biopharma Inc (CUE)

Track

The most recent insider trading activity occurred on December 30, 2025, with multiple buy transactions by Sarraf Pasha. Prior to this, on December 29, 2025, there was a proposed sale by MATTEO GIACOMO LEVISETTI. Earlier significant buy transactions were noted in December 2024 and August 2023.
Stock chart
Ticker: CUE Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Sarraf Pasha
5 purchases — total 99,747 USD
Buy 30 Dec 2025
Value US$3,986,671.78 | Price 489.62 | Shares 71,297
Buy 30 Dec 2025
Value US$2,697,469.27 | Price 471.19 | Shares 66,462
Buy 30 Dec 2025
Value US$27,596.98 | Price 0.32 | Shares 86,947
Buy 30 Dec 2025
Value US$23,167.54 | Price 0.30 | Shares 77,148
Buy 30 Dec 2025
Value US$1,308.45 | Price 0.31 | Shares 4,229
Proposed sale 29 Dec 2025
Value US$3,774,064.44 | Price 269.02 | Shares 92,267
Buy 16 Dec 2024
Value US$30,900.00 | Price 1.03 | Shares 30,000
Buy 25 Aug 2023
Value US$11,040.00 | Price 2.76 | Shares 4,000
Buy 14 Aug 2023
Value US$8,580.00 | Price 2.86 | Shares 3,000
Sale 23 Mar 2023
Value US$30,586.00 | Price 3.28 | Shares 9,325
Buy 27 May 2022
Value US$105,000.00 | Price 3.75 | Shares 28,000
Buy 24 May 2022
Value US$183,700.00 | Price 3.34 | Shares 55,000
Buy 23 May 2022
Value US$528,000.00 | Price 3.52 | Shares 150,000
Buy 31 Mar 2022
Value US$3,498,600.00 | Price 4.76 | Shares 735,000
Planned sale 16 Nov 2021
Value US$24,525.22 | Price 18.02 | Shares 1,361
Planned sale 15 Nov 2021
Value US$337,164.80 | Price 17.92 | Shares 18,815
Planned sale 15 Nov 2021
Value US$144,400.00 | Price 18.05 | Shares 8,000
Planned sale 11 Nov 2021
Value US$301,354.00 | Price 15.07 | Shares 20,000
Planned sale 1 Oct 2021
Value US$17,782.84 | Price 14.21 | Shares 1,251
Buy 24 Sep 2021
Value US$50,051.40 | Price 14.72 | Shares 3,400
Planned sale 23 Sep 2021
Value US$304,646.00 | Price 15.23 | Shares 20,000
Planned sale 16 Mar 2021
Value US$6,625.65 | Price 15.09 | Shares 439
Planned sale 15 Mar 2021
Value US$196,268.80 | Price 15.10 | Shares 13,000
Planned sale 17 Feb 2021
Value US$64,345.07 | Price 15.06 | Shares 4,274
Planned sale 16 Feb 2021
Value US$242,422.40 | Price 15.15 | Shares 16,000
Buy 20 Jan 2021
Value US$40,979.52 | Price 15.07 | Shares 2,720
Buy 24 Nov 2020
Value US$82,775.89 | Price 12.64 | Shares 6,548
Buy 30 Sep 2020
Value US$76,500.00 | Price 15.30 | Shares 5,000
Buy 29 Sep 2020
Value US$75,000.00 | Price 15.00 | Shares 5,000
Planned sale 5 Aug 2020
Value US$265,480.00 | Price 20.00 | Shares 13,274
Planned sale 5 Aug 2020
Value US$16,008.00 | Price 20.01 | Shares 800
Planned sale 4 Aug 2020
Value US$8,056.00 | Price 20.14 | Shares 400
Planned sale 4 Aug 2020
Value US$4,030.05 | Price 20.05 | Shares 201
Planned sale 3 Aug 2020
Value US$116,058.00 | Price 20.01 | Shares 5,800
Planned sale 3 Aug 2020
Value US$128,500.00 | Price 20.00 | Shares 6,425
Buy 24 Jun 2020
Value US$74,533.72 | Price 25.24 | Shares 2,953
Buy 24 Jun 2020
Value US$112,038.08 | Price 24.64 | Shares 4,547
Sale 31 Dec 2019
Value US$141,390.00 | Price 15.71 | Shares 9,000
Sale 31 Dec 2019
Value US$105,659.00 | Price 15.77 | Shares 6,700
Sale 27 Dec 2019
Value US$155,160.00 | Price 17.24 | Shares 9,000
Sale 26 Dec 2019
Value US$344,411.91 | Price 17.53 | Shares 19,647
Sale 23 Dec 2019
Value US$285,940.00 | Price 16.82 | Shares 17,000
Sale 19 Dec 2019
Value US$68,000.00 | Price 17.00 | Shares 4,000
Sale 17 Dec 2019
Value US$326,114.36 | Price 15.73 | Shares 20,732
Buy 21 Jun 2019
Value US$9,997.02 | Price 7.26 | Shares 1,377
Buy 10 Jun 2019
Value US$118,458.34 | Price 7.93 | Shares 14,938
Buy 6 Jun 2019
Value US$14,200.00 | Price 7.10 | Shares 2,000
Buy 6 Jun 2019
Value US$20,700.00 | Price 6.90 | Shares 3,000
Buy 31 Dec 2018
Value US$85,937.44 | Price 4.64 | Shares 18,521
Buy 28 Dec 2018
Value US$32,340.00 | Price 4.62 | Shares 7,000
Buy 27 Dec 2018
Value US$95,400.00 | Price 4.77 | Shares 20,000
Buy 26 Dec 2018
Value US$84,285.63 | Price 4.29 | Shares 19,647
Buy 24 Dec 2018
Value US$48,100.00 | Price 4.81 | Shares 10,000
Buy 21 Dec 2018
Value US$8,740.00 | Price 4.37 | Shares 2,000
Buy 21 Dec 2018
Value US$77,916.00 | Price 4.53 | Shares 17,200
Buy 21 Dec 2018
Value US$44,900.00 | Price 4.49 | Shares 10,000
Buy 20 Dec 2018
Value US$44,736.12 | Price 4.74 | Shares 9,438
Buy 19 Dec 2018
Value US$2,000.00 | Price 5.00 | Shares 400
Buy 18 Dec 2018
Value US$19,052.80 | Price 5.20 | Shares 3,664
Buy 17 Dec 2018
Value US$54,800.00 | Price 5.48 | Shares 10,000
Buy 13 Dec 2018
Value US$50,600.00 | Price 5.06 | Shares 10,000
Buy 12 Dec 2018
Value US$16,168.23 | Price 5.07 | Shares 3,189
Buy 12 Dec 2018
Value US$45,810.00 | Price 5.09 | Shares 9,000
Buy 11 Dec 2018
Value US$36,658.98 | Price 4.86 | Shares 7,543
Buy 29 Aug 2018
Value US$8,480.00 | Price 8.48 | Shares 1,000
Buy 16 Aug 2018
Value US$48,510.00 | Price 8.09 | Shares 6,000
Buy 29 Jun 2018
Value US$19,152.00 | Price 11.97 | Shares 1,600
Buy 27 Dec 2017
Value US$15,000.00 | Price 7.50 | Shares 2,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
71,297 -2.9%
489.62
US$3,986,672 		71,297 -2.9% 489.62 US$3,986,672
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
66,462 -40.9%
471.19
US$2,697,469 		66,462 -40.9% 471.19 US$2,697,469
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
23,479 -8.4%
85.78
US$1,786,666 		23,479 -8.4% 85.78 US$1,786,666
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
77,148 +1824.3%
0.30
US$23,168 		77,148 +1824.3% 0.30 US$23,168
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
4,229 +inf%
0.31
US$1,308 		4,229 +inf% 0.31 US$1,308
2025-12-29 2025-12-29 PrS Proposed sale
MATTEO GIACOMO LEVISETTI

Officer

Officer
7,230
0.26
US$1,907 		7,230 0.26 US$1,907
2024-12-18 2024-12-16 B Purchase
2.5
PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER

Executive Director
30,000 +22.3%
1.03
US$30,900 		30,000 +22.3% 1.03 US$30,900
2023-08-29 2023-08-25 B Purchase
1.4
Suri Anish

PRESIDENT AND CSO

Officer
4,000 +3.0%
2.76
US$11,040 		4,000 +3.0% 2.76 US$11,040
2023-08-16 2023-08-14 B Purchase
2.5
PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER

Executive Director
3,000 +2.3%
2.86
US$8,580 		3,000 +2.3% 2.86 US$8,580
2023-03-27 2023-03-23 S Sale
0.6
Kiener Peter A
Non-Executive Director
9,325 -96.3%
3.28
US$30,586 		9,325 -96.3% 3.28 US$30,586
2022-05-31 2022-05-27 B Purchase
0.6
Morich Frank
Non-Executive Director
28,000 +inf%
3.75
US$105,000 		28,000 +inf% 3.75 US$105,000
2022-05-25 2022-05-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
55,000 +6.2%
3.34
US$183,700 		55,000 +6.2% 3.34 US$183,700
2022-05-25 2022-05-23 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
150,000 +20.4%
3.52
US$528,000 		150,000 +20.4% 3.52 US$528,000
2022-04-04 2022-03-31 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
735,000 +inf%
4.76
US$3,498,600 		735,000 +inf% 4.76 US$3,498,600
2021-11-17 2021-11-16 PlS Planned sale
0.6
Kiener Peter A
Non-Executive Director
1,361 -100.0%
18.02
US$24,525 		1,361 -100.0% 18.02 US$24,525
2021-11-17 2021-11-15 PlS Planned sale
0.6
Kiener Peter A
Non-Executive Director
18,815 -100.0%
17.92
US$337,165 		18,815 -100.0% 17.92 US$337,165
2021-11-17 2021-11-15 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
8,000 -7.8%
18.05
US$144,400 		8,000 -7.8% 18.05 US$144,400
2021-11-15 2021-11-11 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
20,000 -17.5%
15.07
US$301,354 		20,000 -17.5% 15.07 US$301,354
2021-10-05 2021-10-01 PlS Planned sale
Millar Kerri-Ann

CHIEF FINANCIAL OFFICER

Officer
1,251 -10.7%
14.21
US$17,783 		1,251 -10.7% 14.21 US$17,783
2021-09-27 2021-09-24 B Purchase
2.5
PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER

Executive Director
3,400 +6.5%
14.72
US$50,051 		3,400 +6.5% 14.72 US$50,051
2021-09-27 2021-09-23 PlS Planned sale
1.4
Suri Anish

PRESIDENT AND CSO

Officer
20,000 -21.1%
15.23
US$304,646 		20,000 -21.1% 15.23 US$304,646
2021-03-17 2021-03-16 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
439 -18.0%
15.09
US$6,626 		439 -18.0% 15.09 US$6,626
2021-03-17 2021-03-15 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
13,000 -86.7%
15.10
US$196,269 		13,000 -86.7% 15.10 US$196,269
2021-02-18 2021-02-17 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
4,274 -68.1%
15.06
US$64,345 		4,274 -68.1% 15.06 US$64,345
2021-02-18 2021-02-16 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
16,000 -88.9%
15.15
US$242,422 		16,000 -88.9% 15.15 US$242,422
2021-01-22 2021-01-20 B Purchase
0.8
Pienta Kenneth

Chief Medical Officer

Officer
2,720 +136.0%
15.07
US$40,980 		2,720 +136.0% 15.07 US$40,980
2020-11-25 2020-11-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
6,548 +4.1%
12.64
US$82,776 		6,548 +4.1% 12.64 US$82,776
2020-10-01 2020-09-30 B Purchase
1.0
Gray Cameron
Non-Executive Director
5,000 +0.7%
15.30
US$76,500 		5,000 +0.7% 15.30 US$76,500
2020-10-01 2020-09-29 B Purchase
1.0
Gray Cameron
Non-Executive Director
5,000 +0.7%
15.00
US$75,000 		5,000 +0.7% 15.00 US$75,000
2020-08-07 2020-08-05 PlS Planned sale
2.0
Sandercock Colin

SVP, General Counsel and Sec

Officer
13,274 -43.7%
20.00
US$265,480 		13,274 -43.7% 20.00 US$265,480
2020-08-07 2020-08-05 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
800 -2.3%
20.01
US$16,008 		800 -2.3% 20.01 US$16,008
2020-08-05 2020-08-04 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
400 -1.1%
20.14
US$8,056 		400 -1.1% 20.14 US$8,056
2020-08-05 2020-08-04 PlS Planned sale
2.0
Sandercock Colin

SVP, General Counsel and Sec

Officer
201 -1.2%
20.05
US$4,030 		201 -1.2% 20.05 US$4,030
2020-08-05 2020-08-03 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
5,800 -14.4%
20.01
US$116,058 		5,800 -14.4% 20.01 US$116,058
2020-08-05 2020-08-03 PlS Planned sale
2.0
Sandercock Colin

SVP, General Counsel and Sec

Officer
6,425 -27.3%
20.00
US$128,500 		6,425 -27.3% 20.00 US$128,500
2020-06-25 2020-06-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
2,953 +1.9%
25.24
US$74,534 		2,953 +1.9% 25.24 US$74,534
2020-06-25 2020-06-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
4,547 +3.0%
24.64
US$112,038 		4,547 +3.0% 24.64 US$112,038
2019-12-31 2019-12-31 S Sale MARLETT CHRISTOPHER A Non-Executive Director
9,000 -100.0%
15.71
US$141,390 		9,000 -100.0% 15.71 US$141,390
2019-12-31 2019-12-31 S Sale MARLETT CHRISTOPHER A Non-Executive Director
6,700 -0.9%
15.77
US$105,659 		6,700 -0.9% 15.77 US$105,659
2019-12-31 2019-12-27 S Sale MARLETT CHRISTOPHER A Non-Executive Director
9,000 -1.1%
17.24
US$155,160 		9,000 -1.1% 17.24 US$155,160
2019-12-27 2019-12-26 S Sale MARLETT CHRISTOPHER A Non-Executive Director
19,647 -2.4%
17.53
US$344,412 		19,647 -2.4% 17.53 US$344,412
2019-12-27 2019-12-23 S Sale MARLETT CHRISTOPHER A Non-Executive Director
17,000 -2.1%
16.82
US$285,940 		17,000 -2.1% 16.82 US$285,940
2019-12-19 2019-12-19 S Sale MARLETT CHRISTOPHER A Non-Executive Director
4,000 -0.5%
17.00
US$68,000 		4,000 -0.5% 17.00 US$68,000
2019-12-19 2019-12-17 S Sale MARLETT CHRISTOPHER A Non-Executive Director
20,732 -2.5%
15.73
US$326,114 		20,732 -2.5% 15.73 US$326,114
2019-06-25 2019-06-21 B Purchase
2.5
PASSERI DANIEL R

CEO and President

Executive Director
1,377 +2.7%
7.26
US$9,997 		1,377 +2.7% 7.26 US$9,997
2019-06-10 2019-06-10 B Purchase
2.0
Sandercock Colin

SVP, General Counsel and Sec
14,938 +746.9%
7.93
US$118,458 		14,938 +746.9% 7.93 US$118,458
2019-06-10 2019-06-06 B Purchase
2.0
Sandercock Colin

SVP, General Counsel and Sec
2,000 +inf%
7.10
US$14,200 		2,000 +inf% 7.10 US$14,200
2019-06-07 2019-06-06 B Purchase
2.5
PASSERI DANIEL R

CEO and President

Executive Director
3,000 +6.3%
6.90
US$20,700 		3,000 +6.3% 6.90 US$20,700
2019-01-02 2018-12-31 B Purchase
3.9
MARLETT CHRISTOPHER A
Non-Executive Director
18,521 +26.1%
4.64
US$85,937 		18,521 +26.1% 4.64 US$85,937
2019-01-02 2018-12-28 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
7,000 +14.0%
4.62
US$32,340 		7,000 +14.0% 4.62 US$32,340
2018-12-28 2018-12-27 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
20,000 +66.7%
4.77
US$95,400 		20,000 +66.7% 4.77 US$95,400
2018-12-27 2018-12-26 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
19,647 +38.2%
4.29
US$84,286 		19,647 +38.2% 4.29 US$84,286
2019-01-04 2018-12-24 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
10,000 +50.0%
4.81
US$48,100 		10,000 +50.0% 4.81 US$48,100
2018-12-26 2018-12-21 B Purchase Suri Anish

Chief Scientific Officer

Officer
2,000 +inf%
4.37
US$8,740 		2,000 +inf% 4.37 US$8,740
2018-12-26 2018-12-21 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
17,200 +50.2%
4.53
US$77,916 		17,200 +50.2% 4.53 US$77,916
2018-12-26 2018-12-21 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
10,000 +100.0%
4.49
US$44,900 		10,000 +100.0% 4.49 US$44,900
2018-12-21 2018-12-20 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
9,438 +38.1%
4.74
US$44,736 		9,438 +38.1% 4.74 US$44,736
2018-12-20 2018-12-19 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
400 +1.6%
5.00
US$2,000 		400 +1.6% 5.00 US$2,000
2018-12-19 2018-12-18 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
3,664 +17.7%
5.20
US$19,053 		3,664 +17.7% 5.20 US$19,053
2018-12-18 2018-12-17 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
10,000 +inf%
5.48
US$54,800 		10,000 +inf% 5.48 US$54,800
2018-12-17 2018-12-13 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
10,000 +93.2%
5.06
US$50,600 		10,000 +93.2% 5.06 US$50,600
2018-12-13 2018-12-12 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
3,189 +42.3%
5.07
US$16,168 		3,189 +42.3% 5.07 US$16,168
2018-12-13 2018-12-12 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
9,000 +inf%
5.09
US$45,810 		9,000 +inf% 5.09 US$45,810
2018-12-12 2018-12-11 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
7,543 +inf%
4.86
US$36,659 		7,543 +inf% 4.86 US$36,659
2018-08-29 2018-08-29 B Purchase Millar Kerri-Ann

VP-Finance

Officer
1,000 +inf%
8.48
US$8,480 		1,000 +inf% 8.48 US$8,480
2018-08-20 2018-08-16 B Purchase PASSERI DANIEL R

CEO and President

Executive Director
6,000 +14.4%
8.09
US$48,510 		6,000 +14.4% 8.09 US$48,510
2018-06-29 2018-06-29 B Purchase PASSERI DANIEL R

CEO and President

Executive Director
1,600 +4.0%
11.97
US$19,152 		1,600 +4.0% 11.97 US$19,152
2018-01-19 2017-12-27 B Purchase Pienta Kenneth

Chief Medical Officer

Officer
2,000 +inf%
7.50
US$15,000 		2,000 +inf% 7.50 US$15,000
Explore more

More insider trading research around Cue Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America